Short Interest Don’t Lie: Enteromedics Incorporated (NASDAQ:ETRM) Reports Increase in Sellers; Strong Momentum for Short Players

January 11, 2017 - By Peter Erickson   ·   0 Comments

Short Interest Don't Lie: Enteromedics Incorporated (NASDAQ:ETRM) Reports Increase in Sellers; Strong Momentum for Short Players

The stock of Enteromedics Incorporated (NASDAQ:ETRM) registered an increase of 45.24% in short interest. ETRM’s total short interest was 10.48M shares in January as published by FINRA. Its up 45.24% from 7.21M shares, reported previously. With 19.21M shares average volume, it will take short sellers 1 days to cover their ETRM’s short positions. About 9.87M shares traded hands or 146.75% up from the average. EnteroMedics Inc (NASDAQ:ETRM) has declined 17.56% since June 7, 2016 and is downtrending. It has underperformed by 24.98% the S&P500.

EnteroMedics Inc. is a medical device company. The company has a market cap of $63.38 million. The Firm is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. It currently has negative earnings. The Company’s neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve.

ETRM Company Profile

EnteroMedics Inc. (EnteroMedics), incorporated on July 22, 2004, is a medical device company. The Firm is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company’s neuroblocking technology, which is referred to as VBLOC therapy, is designed to block the vagus nerve. The Company’s initial product is the Maestro Rechargeable System, which uses VBLOC therapy to limit the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness.

More recent EnteroMedics Inc (NASDAQ:ETRM) news were published by: Prnewswire.com which released: “EnteroMedics Announces Retirement of All Senior Convertible Notes” on December 29, 2016. Also Prnewswire.com published the news titled: “EnteroMedics Announces vBloc® Neurometabolic Therapy Now Available at MedStar …” on January 05, 2017. Benzinga.com‘s news article titled: “How You Should Approach The Move In EnteroMedics” with publication date: January 10, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Peter Erickson

Tags: , ,


Readers Comments (0)





>